Supplementation of selenium reduces chemical hepatocarcinogenesis in male Sprague-Dawley rats

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 2, 2010, Pages 119-123

  Alwahaibi, Nasar ^a   Mohamed, Jamaludin ^a   Alhamadani, Asha ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

DEN; Hepatocarcinogenesis; Selenium

Indexed keywords

DIETHYLNITROSAMINE; DRINKING WATER; EOSIN; HEMATOXYLIN; N (2 FLUORENYL)ACETAMIDE; SELENIUM; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPERIMENTAL RAT; LIVER; LIVER CANCER; LIVER SIZE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STAINING; TREATMENT DURATION;

ALKYLATING AGENTS; ANIMALS; DIETHYLNITROSAMINE; HUMANS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SODIUM SELENITE;

ANIMALIA; RATTUS;

EID: 77952888746     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2009.09.003     Document Type: Article

References (42)

1. Parkin D., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA. Cancer J Clin 2005, 55(2):74-108.
2. But D., Lai C., Yuen M. Natural history of hepatitis related hepatocellular carcinoma. World J Gastroenterol 2008, 14(11):1652-1656.
3. Gurusamy K. Trace element concentration in primar liver cancers - a systematic review. Biol Trace Res 2007, 118:191-206.
4. Jacobs M., Frost C. Toxicological effects of sodium selenite in Sprague-Dawley rats. J Toxicol Environ Health 1981, 8:575-585.
5. Tapiero H., Townsend D., Tew K. The antioxidant role f selenium and seleno-compounds. Biomed Pharmacother 2003, 57:134-144.
6. Clark L., Combs G., Turnbull B., State E. The nutritional prevention of cancer with selenium 1983-1993: a randomized clinical trial. JAMA 1996, 276:1957-1963.
7. Björkhem-Bergman L., Torndal U., Eken S., Nyström C. Selenium prevents tumor development in rat module for chemical carcinogenesis. Carcinogenesis 2005, 26(1):125-131.
8. Ujiie S., Itoh Y., Kikuchi H. Serum selenium contents and the risk of cancer. Gan To Kagaku Ryoho 1998, 25:1891-1897.
9. Prasad M., Mukunda M., Krishnaswamy K. Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity. Eur J Cancer B Oral Oncol 1995, 31:155-159.
10. Yu S., Zhu Y., Li W. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 1997, 56:117-124.
11. Bonelli L., Camoriano P., Ravelli G., Missale P. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. In: Palmier Y, editor. Proceedings of International Selenium Tellurium Development Association, Scottsdale, 1998. p. 91-4.
12. Combs G., Combs S. Selenium and cancer. The role of selenium in nutrition 1986, 413-462. Academic Press, San Diego. G. Combs, S. Combs (Eds.).
13. Thirunavukkarasu C., Sakthisekaran D. Effect of dietary selenite on N-nitrosodiethylamine induced and Phenobarbital promoted multistage hepatocarcinogenesis in rats; reflection in some minerals. Biomedicine and Pharmacotherapy 2003, 57:416-421.
14. Dorado R., Porta E., Aquino T. Effects of dietary selenium hepatic and renal tumorigenesis induced in rats by diethyl nitrosamine. Hepatology 1985, 5:1201-1208.
15. Yu S., Chu Y., Gong X., Hau C. Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol Trace Elem Res 1985, 7:21-29.
16. Knekt P., Aromaa A., Maatela J. Serum selenium and subsequent risk of cancer among Finnish men and women. J Nat Cancer Inst 1990, 82:864-868.
17. Li J., Blot W., Taylor P. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995, 62:1424s-1426s.
18. Solt D., Farber E. New principle for the analysis of chemical analysis. Nature 1976, 263:701-703.
19. Moreno F., Rizzi M., Pagli Z., Penteado M. Inhibitory effect of Β-carotene on preneoplastic lesions induced in Wister rats by the resistant hepatocyte model. Carcinogenesis 1991, 12:1817-1822.
20. Reid M., Stratton M., Lillico A., Fakih M., Natarajan K., Clark L., Marshall J. A report of high dose selenium supplementation: response and toxicities. J Trace Elem Med Biol 2004, 18:69-74.
21. Yang G., Wang S., Zhou R., Sun S. Endemic selenium intoxication of humans in China. Am J Clin Nutr 1983, 37:872-881.
22. Selenium IOM. In: Dietary reference intakes for ascorbic acid, vitamin E, selenium, and carotenoids. Food and Nutrition Board, Institute of Medicine. Washington DC: National academy Press; 2000. [accessed September 2008]. http://www.iom.edu.
23. LeBoeuf R., Laishes B., Hoekstra W. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethyl nitrosamine or N-acetylaminofluorene in rats. Cancer Res 1985, 45:5489-5495.
24. Mukherjee B., Ghosh S., Chatterjee M. Biochemical basis of selenomethionine-mediated inhibition during 2-AAF induced hepatocarcinogenesis in the rat. Eur J Cancer Prev 1996, 5:455-463.
25. Lippman S.M., Klein E.A., Goodman M.S. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301(1):39-51.
26. Stranges S., Marshall J.R., Natarajan R. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147(4):217-223.
27. Thirunavukkarasu C., Jagadeeswaran R., Babu E., Sakthisekaran D. Inhibitory effect of selenium on N-nitrosodiethylamine-induced and Phenobarbital promoted rat liver carcinogenesis. JCBN 2000, 28:69-80.
28. Bannasch P. Preneoplastic lesions as end points in carcinogencity testing.1. Hepatic preneoplasia. Carcinogenesis 1986, 7(5):689-695.
29. Farber E. Clonal adaptation during carcinogenesis. Biochem Pharmacol 1990, 39:1837-1846.
30. Taylor P.R. Science peels the onion of selenium effects on prostate carcinogenesis. JNCI 2004, 96(6):645-647.
31. Sinha R., El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemotherapy by selenium compounds. Curr Cancer Drug Targets 2004, 4(1):13-28.
32. Higgins G., Anderson M. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12:186-202.
33. Itze L., Vesselinovitch D., Rao V. Estimation of the rate of DNA synthesis in newborn, regenerating and intact mice livers. Physiol Bohemoslov 1973, 22:457-460.
34. Sell S., Nichols M., Becker F., Leffert H. Hepatocyte proliferation and alpha 1-fetoprotein in pregnant, neonatal, and partially hepatectomized rats. Cancer Res 1974, 34:865-871.
35. Laconi E., Tessitore L., Milia G., Yusuf A., Sarma D., Todde P., et al. The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis 1995, 16:1865-1869.
36. Tessitore l, Tomasi C., Greco M., Sesca E., Laconi E., Maccioni O., et al. A subnecrogenic dose of diethyl nitrosamine is able to initiate hepatocarcinogenesis in the rat when coupled with fasting/refeeding. Carcinogenesis 1996, 17:289-292.
37. Tomasi C., Lacon E., Laconi S., Greco M., Sarma D., Pani P. Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis 1999, 20:1979-1983.
38. Lee B., Lee S. Preventives effects of a mixed disulphide from dithiocarbamate and N-acetylcysteine on the genotoxicity of N-nitrosodiethylamine. J Pharm Pharmacol 1999, 51:105-109.
39. Gupta R., Earley K., Becker F. Analysis of DNA adducts in putative premalignant hepatic nodules and nontarget tissues of rats during 2-acetylaminofluorene carcinogenesis. Cancer Res 1988, 48(18):5270-5274.
40. Camargo J., Tsuda H., Asamoto M. Modifying effects of chemicals on the development of liver preneoplastic placental glutathione S-transferase positive foci in anal-buminemic and Sprague-Dawley rats. Toxicol Pathol 1993, 21:409-416.
41. Bitsch A., Hadjiolov N., Klohn P. Dose response of early effects related to tumor promotion of 2-acetylaminofluorene. Toxicol Sci 2000, 55:44-51.
42. Tatematsu M., Mera Y., Ito N., Satoh K., Sato K. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985, 6(11):1621-1626.